Schedule 13G ownership disclosure

CELLECT BIOTECHNOLOGY LTD

Security class unavailable · CUSIP: 15116C201

Event date: 2020-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
30,500,000
Percent of class
9.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-004930
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Jan 17, 2020
Reporting period
Jan 08, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub